Patenting and licensing of inventions is a critical first step in the product development and commercialization process.
The New Ventures (NV) group is the first point of contact for UMass Chan researchers and external partners alike. This group is responsible for proactively scouting UMass Chan Medical School to identify and evaluate commercializable assets and platform technology and match them with potential partners in biotech, pharma and investor ecosystem.